Novel Stem Cell Technique in Pre-Clinical Models of Parkinson's Disease

On Sunday, November 6, Lorenz Studer, MD, director of the Sloan Kettering Institute (SKI) for Stem Cell Biology, published a paper in the journal Nature on a new strategy for using embryonic stem (ES) cells to graft human dopamine neurons into pre-clinical models of Parkinson’s disease (PD). Historically, ES cells have shown promise for treating PD in a Petri dish, they have not yet been effective once transplanted into a living organism. Dr. Studer’s new technique, however, has revealed new promise in models of PD, reflecting the potential for dopamine cells’ survival and function in the brain.

See full story:

http://www.michaeljfox.org/living_viewpoints_newsInContext_article.cfm?ID=37